Cell protection of allopurinol during ischemia-reperfusion in the lung.

别嘌呤醇在肺缺血再灌注过程中的细胞保护作用。

基本信息

  • 批准号:
    05671258
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

Tangstate enriched diet for 3-4 weeks depleted the lung XD and XO by 80%. Using isolated perfused lungs of these rats, 90 minutes ischemia and reperfusion were performed. The lungs of XO deficient rats were protected from ischemia reperfusion injury as compared with the lungs of normal rats. Allopurinol, XO inhibitor was also effective to protect the lungs from ischemia-reperfusion. Therefore it is clear that XO mediates ischemia-reperfusion injury in the lung. In another experiment, SOD and catalase, oxygen radical scavenger, also protected the lungs from 60 minutes ischemia and reperfusion, which indicates that oxygen radicals involves in lung ischemia-reperfusion injury. On the other hand, we found that XD to XO conversion was not occurred by 90 minutes ischemia. Moreover, continuous ventilation during ischemia with 100 N2 decreased ischemia-reperfusion lung injury. These results suggest that XO is unlikely to be a main source of oxygen radical after reperfusion.Recent reports demonstrated that the main source of oxygen radicals after ischemia-reperfusion was polymorphonuclear leukocyte (PMN) and tissue fixed macrophage. In addition, Terada reported that tungstate diet prevent leukocyte accumulation in the lung after intestinal ischemia. Therefore, XD and XO may contribute to PMN activation during ischemia-reperfusion.
3-4周的Tangstate强化饮食消耗了80%的肺XD和XO。采用离体肺灌流,进行90分钟缺血再灌注。与正常大鼠相比,XO缺陷大鼠肺对缺血再灌注损伤具有保护作用。XO抑制剂别嘌呤醇对肺缺血再灌注损伤也有保护作用。因此,很明显,XO介导肺缺血-再灌注损伤。在另一实验中,SOD和过氧化氢酶(氧自由基清除剂)也对肺缺血再灌注60分钟有保护作用,表明氧自由基参与了肺缺血再灌注损伤。另一方面,我们发现缺血90分钟后,XD尚未发生向XO的转化。此外,在缺血期间用100 N2持续通气减少缺血再灌注肺损伤。这些结果表明XO不是再灌注后氧自由基的主要来源,最近的研究表明,缺血再灌注后氧自由基的主要来源是多形核白细胞(PMN)和组织固定的巨噬细胞。此外,Terada报道,钨酸盐饮食可防止肠缺血后肺中白细胞积聚。因此,XD和XO可能有助于在缺血再灌注期间激活PMN。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kazuhisa Furuhashi: "Ischemia-reperfusion does not inpair condotherium-dependent relaxation in isolated perfusion rat lings" Mie Medical Journal. 44. 83-89 (1994)
Kazuhisa Furuhashi:“缺血再灌注不会损害离体灌注大鼠的血管依赖性松弛”三重医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
OKUDA,M.: "Decrease of ischemia-reperfusion related lung cedema by continuous ventilation and allopurinol in rat perfused lung model." Scand.J.Clin.Lab.Invest. 53. 625-631 (1993)
OKUDA,M.:“在大鼠灌注肺模型中通过持续通气和别嘌呤醇减少缺血再灌注相关的肺水肿。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiro Okuda.et al.: "Attenuation of ischemia-reperfusion lung edewa by postaglation In analoge" J. of Anesth.8. 450-454 (1994)
Masahiro Okuda.et al.:“Anesth J. 8.通过类似的 postaglation 来减弱缺血再灌注肺水肿”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiro Okuda et al.: "Dccrease of ischemia-reperfusion related lung oedema by continuous ventilation and allopurinal in rat perfusion by model" Scand. J. Clin Lab Invost. 33. 625-631 (1993)
Masahiro Okuda 等人:“通过模型持续通气和大鼠灌注中的别嘌呤减少缺血再灌注相关的肺水肿” Scand。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masahiro Okuda et al: "Decrase of ischemia-reperfusion relutid lung cridemcs by continueus vetilation" Scand.J.Clin Lab.Invest.53. 625-631 (1993)
Masahiro Okuda 等人:“通过持续通气减少缺血再灌注严重的肺部危险” Scand.J.Clin Lab.Invest.53。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKUDA Masahiro其他文献

OKUDA Masahiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKUDA Masahiro', 18)}}的其他基金

Development of novel preventive method for cisplatin-induced nephrotoxicity with drug-drug interaction
开发新的药物-药物相互作用预防顺铂肾毒性方法
  • 批准号:
    17K08412
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of microRNA on the pharmacokinetics of calcineurin inhibitors after living liver transplantation
microRNA对活体肝移植后钙调神经磷酸酶抑制剂药代动力学的作用
  • 批准号:
    26460196
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on surveillance system with high dynamic range cameras
高动态范围摄像机监控系统研究
  • 批准号:
    24560473
  • 财政年份:
    2012
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of functions of drug transporters in renal tubules by inflammatory cytokines and implication of its significance
炎症细胞因子对肾小管药物转运蛋白功能的调节及其意义
  • 批准号:
    23590180
  • 财政年份:
    2011
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Expression and functions of drug transporters in renal tubules by kidney-specific oxidative stress and its role
肾脏特异性氧化应激作用下肾小管药物转运蛋白的表达和功能及其作用
  • 批准号:
    20590143
  • 财政年份:
    2008
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on real time compression of 3D images based on planar approximation using PC clusters
基于PC集群平面逼近的3D图像实时压缩研究
  • 批准号:
    20760244
  • 财政年份:
    2008
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Evaluation and estimation of renal drug elimination based on promoter analyses of organic cation transporters
基于有机阳离子转运蛋白启动子分析的肾脏药物消除评估和估计
  • 批准号:
    17590119
  • 财政年份:
    2005
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of gene expression mechanisms of kidney-specific organic cation transporter OCT2 by promoter analyses.
通过启动子分析阐明肾脏特异性有机阳离子转运蛋白 OCT2 的基因表达机制。
  • 批准号:
    15590128
  • 财政年份:
    2003
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study of light stimulus propagation phenomena in optical information processing media, liquid crystals
光信息处理介质液晶中光刺激传播现象的研究
  • 批准号:
    02805037
  • 财政年份:
    1990
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
  • 批准号:
    23K21458
  • 财政年份:
    2024
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation
开发合成肝素以保护移植肝免受移植过程中的缺血再灌注损伤
  • 批准号:
    10759102
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Nck1 in Ischemia Reperfusion Injury
Nck1在缺血再灌注损伤中的作用
  • 批准号:
    10715406
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
  • 批准号:
    10606952
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
  • 批准号:
    10652915
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Ischemia/Reperfusion injury and Myocardial edema
缺血/再灌注损伤和心肌水肿
  • 批准号:
    10718260
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Role of Gasdermin D/E in intestinal ischemia-reperfusion injury
Gasdermin D/E 在肠缺血再灌注损伤中的作用
  • 批准号:
    23K15529
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Monocytic-MDSCs as resolution mediators of post-transplant lung ischemia-reperfusion injury
单核细胞-MDSC作为移植后肺缺血再灌注损伤的解决介质
  • 批准号:
    10677290
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Role of Lipid Metabolism in Hepatic Ischemia Reperfusion Injury in Steatotic Livers
脂质代谢在脂肪肝缺血再灌注损伤中的作用
  • 批准号:
    10664736
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
ETS2-dependent control in cardiomyocyte ischemia/reperfusion injury
ETS2 依赖性控制心肌细胞缺血/再灌注损伤
  • 批准号:
    10501545
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了